Literature DB >> 6260649

Acute cytomegalovirus infections in leukemic mice.

D R Mayo, F Rapp.   

Abstract

Mice infected with 2 x 10(3) plaque-forming units of mouse cytomegalovirus (MCMV) 3 days after receiving 300 to 400 spleen focus-forming units of Friend leukemia virus developed a more severe MCMV infection than did normal animals. Increased severity was demonstrated by the increased amounts of MCMV recoverable from the salivary glands of leukemic mice 1 to 5 weeks postinfection. In addition, the difference in the number of virus isolations from the kidneys, spleens, livers, and lungs of animals (74 to 120) coinfected with MCMV and Friend leukemia virus compared with animals (49 of 120) infected with MCMV alone was significant (P less than 0.01). Both the 50% lethal dose and 50% infectious dose of MCMV in leukemic mice were lower than in normal animals. MCMV and Friend leukemia virus appear to interact by suppressing the ability of infected spleen cells to respond to mitogen-induced stimulation. The observations of increased severity of MCMV infections in leukemic mice closely parallel the situation observed in human leukemia patients who are at an increased risk of disease due to human cytomegalovirus infections. This mouse model may be useful in assessing the effect of antiviral (cytomegalovirus) therapy.

Entities:  

Mesh:

Year:  1980        PMID: 6260649      PMCID: PMC551118          DOI: 10.1128/iai.29.2.311-315.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation.

Authors:  R H Rubin; P S Russell; M Levin; C Cohen
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

2.  Vertical transmission of murine cytomegalovirus.

Authors:  J K Chantler; V Misra; J B Hudson
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

3.  Intranuclear and Cytoplasmic Inclusions ("Protozoan-Like Bodies") in the Salivary Glands and Other Organs of Infants.

Authors:  S Farber; S B Wolbach
Journal:  Am J Pathol       Date:  1932-03       Impact factor: 4.307

4.  Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection.

Authors:  G D Hsiung; Y C Choi; F Bia
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

Review 5.  Viral infections in man associated with acquired immunological deficiency states.

Authors:  T C Merigan; D A Stevens
Journal:  Fed Proc       Date:  1971 Nov-Dec

6.  Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity.

Authors:  R J Howard; J Miller; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

Review 7.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

Review 8.  Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.

Authors:  A S Levine; S C Schimpff; R G Graw; R C Young
Journal:  Semin Hematol       Date:  1974-04       Impact factor: 3.851

9.  Progressive inhibition of T-cell function preceding clinical signs of cytomegalovirus infection in mice.

Authors:  J Booss; E F Wheelock
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

10.  Diagnosis of cytomegalovirus pneumonia in compromised hosts.

Authors:  P S Abdallah; J B Mark; T C Merigan
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

View more
  1 in total

1.  The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplantation setting.

Authors:  R Agah; A Mazumder
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.